万络（罗非昔布片），适应症为本品适用于：●骨关节炎症状和体征的短期和长期治疗。●缓解疼痛。●治疗原发性痛经。
From "VIOXX accedent"and "Xinfu accedent", we want to find the differecence of tool for the drug risk management and make some feasible suggestions for drug safety management in China.
从"万络事件"和"欣弗事件"中,探寻中美两国对药品风险管理手段的差异,从中为我国药品安全管理提出可行性建议。
参考来源 - 美国药品安全风险管理最终指南对我国药品安全风险管理的启示·2,447,543篇论文数据，部分数据来源于NoteExpress
万络在2004年已经退出市场。
与安慰剂相比，万络和鲁米昔布高于其两倍的心脏病风险。
Compared to placebos, Vioxx and Prexige were associated with twice the risk of heart attack.
批评家们说FDA本应该早点对万络问题的迹象以及市场上其它的药物问题的迹象作出反应的。
Critics said the FDA should have reacted sooner to signs of problems related to Vioxx and other medicines on the market.
应用推荐